M Gulubova, A Tolekova, D Berbatov, I Stefanov, D Chonov, N Aydoglu
{"title":"实验性代谢综合征大鼠肝脏和胆胰轴中胰岛素和胰高血糖素生成细胞的研究。","authors":"M Gulubova, A Tolekova, D Berbatov, I Stefanov, D Chonov, N Aydoglu","doi":"10.1080/13813455.2025.2503482","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>The generation of insulin-producing cells (IPCs) as cell replacement therapy for diabetes treatment is challenging.</p><p><strong>Objective: </strong>We have evaluated the presence of insulin-positive (insulin<sup>+</sup>) and glucagon-positive (glucagon<sup>+</sup>) cells in hepatocytes, peribiliary glands (PBGs), and liver sinusoidal endothelial cells (LSECs).</p><p><strong>Materials and methods: </strong>Wistar rats are subjected to a diet including administration of 15% fructose solution for 3 months. Tissue samples are processed for immunohistochemistry with antibodies against insulin, glucagon, ghrelin, somatostatin, PDX1, and SOX9. Blood glucose levels and lipid profile are investigated.</p><p><strong>Results: </strong>In treated rats, Ins<sup>+</sup> and glucagon<sup>+</sup> hepatocytes are found around central veins. In PBGs, Ins<sup>+</sup> and glucagon<sup>+</sup> endocrine cells (ECs) are detected. LSECs show insulin<sup>+</sup> and glucagon<sup>+</sup> cellular membranes. The nuclei of LSECs in treated rats are SOX9-positive.</p><p><strong>Conclusions: </strong>Our experiment of fructose-induced metabolic syndrome shows the appearance of Ins<sup>+</sup> and glucagon<sup>+</sup> ECs in extrahepatic biliary pathways and hepatocytes. Interestingly, SOX9<sup>+</sup> nuclei of LSECs are observed.</p>","PeriodicalId":8331,"journal":{"name":"Archives of Physiology and Biochemistry","volume":" ","pages":"1-9"},"PeriodicalIF":2.5000,"publicationDate":"2025-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Insulin- and glucagon-producing cells in the liver and biliary-pancreatic axis of rats with experimentally induced metabolic syndrome.\",\"authors\":\"M Gulubova, A Tolekova, D Berbatov, I Stefanov, D Chonov, N Aydoglu\",\"doi\":\"10.1080/13813455.2025.2503482\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Context: </strong>The generation of insulin-producing cells (IPCs) as cell replacement therapy for diabetes treatment is challenging.</p><p><strong>Objective: </strong>We have evaluated the presence of insulin-positive (insulin<sup>+</sup>) and glucagon-positive (glucagon<sup>+</sup>) cells in hepatocytes, peribiliary glands (PBGs), and liver sinusoidal endothelial cells (LSECs).</p><p><strong>Materials and methods: </strong>Wistar rats are subjected to a diet including administration of 15% fructose solution for 3 months. Tissue samples are processed for immunohistochemistry with antibodies against insulin, glucagon, ghrelin, somatostatin, PDX1, and SOX9. Blood glucose levels and lipid profile are investigated.</p><p><strong>Results: </strong>In treated rats, Ins<sup>+</sup> and glucagon<sup>+</sup> hepatocytes are found around central veins. In PBGs, Ins<sup>+</sup> and glucagon<sup>+</sup> endocrine cells (ECs) are detected. LSECs show insulin<sup>+</sup> and glucagon<sup>+</sup> cellular membranes. The nuclei of LSECs in treated rats are SOX9-positive.</p><p><strong>Conclusions: </strong>Our experiment of fructose-induced metabolic syndrome shows the appearance of Ins<sup>+</sup> and glucagon<sup>+</sup> ECs in extrahepatic biliary pathways and hepatocytes. Interestingly, SOX9<sup>+</sup> nuclei of LSECs are observed.</p>\",\"PeriodicalId\":8331,\"journal\":{\"name\":\"Archives of Physiology and Biochemistry\",\"volume\":\" \",\"pages\":\"1-9\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-06-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Physiology and Biochemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/13813455.2025.2503482\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Physiology and Biochemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13813455.2025.2503482","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
Insulin- and glucagon-producing cells in the liver and biliary-pancreatic axis of rats with experimentally induced metabolic syndrome.
Context: The generation of insulin-producing cells (IPCs) as cell replacement therapy for diabetes treatment is challenging.
Objective: We have evaluated the presence of insulin-positive (insulin+) and glucagon-positive (glucagon+) cells in hepatocytes, peribiliary glands (PBGs), and liver sinusoidal endothelial cells (LSECs).
Materials and methods: Wistar rats are subjected to a diet including administration of 15% fructose solution for 3 months. Tissue samples are processed for immunohistochemistry with antibodies against insulin, glucagon, ghrelin, somatostatin, PDX1, and SOX9. Blood glucose levels and lipid profile are investigated.
Results: In treated rats, Ins+ and glucagon+ hepatocytes are found around central veins. In PBGs, Ins+ and glucagon+ endocrine cells (ECs) are detected. LSECs show insulin+ and glucagon+ cellular membranes. The nuclei of LSECs in treated rats are SOX9-positive.
Conclusions: Our experiment of fructose-induced metabolic syndrome shows the appearance of Ins+ and glucagon+ ECs in extrahepatic biliary pathways and hepatocytes. Interestingly, SOX9+ nuclei of LSECs are observed.
期刊介绍:
Archives of Physiology and Biochemistry: The Journal of Metabolic Diseases is an international peer-reviewed journal which has been relaunched to meet the increasing demand for integrated publication on molecular, biochemical and cellular aspects of metabolic diseases, as well as clinical and therapeutic strategies for their treatment. It publishes full-length original articles, rapid papers, reviews and mini-reviews on selected topics. It is the overall goal of the journal to disseminate novel approaches to an improved understanding of major metabolic disorders.
The scope encompasses all topics related to the molecular and cellular pathophysiology of metabolic diseases like obesity, type 2 diabetes and the metabolic syndrome, and their associated complications.
Clinical studies are considered as an integral part of the Journal and should be related to one of the following topics:
-Dysregulation of hormone receptors and signal transduction
-Contribution of gene variants and gene regulatory processes
-Impairment of intermediary metabolism at the cellular level
-Secretion and metabolism of peptides and other factors that mediate cellular crosstalk
-Therapeutic strategies for managing metabolic diseases
Special issues dedicated to topics in the field will be published regularly.